Vol 81, No 2 | The Journal of Clinical Psychiatry

Editorial

COVID-19 From a Psychiatry Perspective: Meeting the Challenges

J Clin Psychiatry 2020;81(2):20ed13358

Marlene P. Freeman, MD

Consensus Statement

A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia

J Clin Psychiatry 2020;81(2):19cs12983

Stanley N. Caroff, MD ; Leslie Citrome, MD, MPH ; Jonathan Meyer, MD ; Martha Sajatovic, MD ; Joseph F. Goldberg, MD ; Rakesh Jain, MD ; Leslie Lundt, MD ; Jean-Pierre Lindenmayer, MD ; Joseph P. McEvoy, MD ; Roger S. McIntyre, MD ; Mauricio Tohen, MD, DrPH, MBA ; Terence A. Ketter, MD

Meta-Analysis

The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses

J Clin Psychiatry 2020;81(2):19r12924

Kriti D. Gandhi, MD^a ; Meghna P. Mansukhani, MD^b ; Victor M. Karpyak, MD, PhD^a ; Terry D. Schneekloth, MD^a ; Zhen Wang, PhD^c ; Bhanu Prakash Kolla, MD, MRCPsych^a,b

Meta-Analysis

Long-Term Outcomes of Postpartum Psychosis: A Systematic Review and Meta-Analysis

J Clin Psychiatry 2020;81(2):19r12906

Janneke Gilden, MD^a ; Astrid M. Kamperman, PhD^a ; Trine Munk-Olsen, PhD^b ; Witte J. G. Hoogendijk, MD, PhD^a ; Steven A. Kushner, MD, PhD^a ; Veerle Bergink, MD, PhD^a,c

Review Article

New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature

J Clin Psychiatry 2020;81(2):19r13027

Emily A. Ferenczi, BM, BCh, PhD^a,b ; Michael G. Erkkinen, MD^a,c ; Mel B. Feany, MD, PhD^d ; Barry S. Fogel, MD^a,c,e ; Kirk R. Daffner, MD^a,c

Review Article

The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration

J Clin Psychiatry 2020;81(2):19r12960

Mathangi Gopalakrishnan, MS, PhD^a ; Hao Zhu, PhD^b ; Tiffany R. Farchione, MD^c ; Mitchell Mathis, MD^c,‡ ; Mehul Mehta, PhD^b ; Ramana Uppoor, PhD^b ; Islam Younis, PhD^b,‡

Review Article

Maintaining Rapid Antidepressant Effects Following Ketamine Infusion: A Major Unmet Need

J Clin Psychiatry 2020;81(2):19r12859

George I. Papakostas, MD

Original Research

Types of Adult Attention-Deficit/Hyperactivity Disorder: A Replication Analysis

J Clin Psychiatry 2020;81(2):19m13077

Frederick W. Reimherr, MD^a,b ; Michael Roesler, MD^c ; Barrie K. Marchant, MS^b ; Thomas E. Gift, MD^d ; Wolfgang Retz, MD^c,e ; Florence Philipp-Wiegmann, MD^c ; Matthew L. Reimherr, PhD^f

Original Research

Suicidality, Depression, and the FDA: Health Inequities and the Ethical Conduct of Research

J Clin Psychiatry 2020;81(2):19m13050

Ana S. Iltis, PhD^a ; William V. McCall, MD, MS^b ; Riyan Deria^c

Original Research

Relationship of Nocturnal Wakefulness to Suicide Risk Across Months and Methods of Suicide

J Clin Psychiatry 2020;81(2):19m12964

Andrew S. Tubbs, BSc^a ; Michael L. Perlis, PhD^b ; Mathias Basner, MD, PhD^b ; Subhajit Chakravorty, MD^b ; Waliuddin Khader, BA^a,c ; Fabian Fernandez, PhD^c ; Michael A. Grandner, PhD, MTR^a

Original Research

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study

J Clin Psychiatry 2020;81(2):19m12961

Tomoyuki Nagata, MD, PhD^a,b ; Shunichiro Shinagawa, MD, PhD^a ; Kazunari Yoshida, MD, PhD^c,d ; Yoshihiro Noda, MD, PhD, MBA^c ; Masahiro Shigeta, MD, PhD^a ; Masaru Mimura, MD, PhD^c ; Shinichiro Nakajima, MD, PhD^c

Original Research

Disordered Aggression and Violence in the United States

J Clin Psychiatry 2020;81(2):19m12937

Emil F. Coccaro, MD^a,‡,* ; Royce J. Lee, MD^a

Original Research

Role of Hopelessness in Suicidal Ideation Among Patients With Depressive Disorders

J Clin Psychiatry 2020;81(2):19m12866

Ilya Baryshnikov, MD, PhD^a ; Tom Rosenström, PhD^b,c ; Pekka Jylhä, MD, PhD^a,d ; Maria Vuorilehto, MD, PhD^a,d ; Mikael Holma, MD, PhD^d,e ; Irina Holma, MD, PhD^a ; Kirsi Riihimäki, MD, PhD^d ; Gregory K. Brown, PhD^f ; Maria A. Oquendo, MD, PhD^f ; Erkki T. Isometsä, MD, PhD^a,d

Original Research

Striatal Resting-State Connectivity Abnormalities Associated With Different Clinical Stages of Major Depressive Disorder

J Clin Psychiatry 2020;81(2):19m12790

Li Wang, PhD^a,b,‡ ; Feng Li, MD^c,d,‡ ; Philip B. Mitchell, PhD^e ; Chuan-Yue Wang, PhD^c,d, ; Tian-Mei Si, PhD^b,

Original Research

Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial

J Clin Psychiatry 2020;81(2):19m12786

Mary F. Brunette, MD^a ; Christoph U. Correll, MD^b,c ; Stephanie S. O' Malley, PhD^d ; David McDonnell, MD^e ; Lauren DiPetrillo, PhD^f ; Ying Jiang, PhD^f ; Adam Simmons, MPH^f ; Bernard L. Silverman, MD^f ; Leslie Citrome, MD, MPH^g ; Alan I. Green, MD^a

Original Research

Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study

J Clin Psychiatry 2020;81(2):19m12769

Steven G. Potkin, MD^a ; Jelena Kunovac, MD^b,c ; Bernard L. Silverman, MD^d ; Adam Simmons, MPH^d ; Ying Jiang, PhD^d ; Lauren DiPetrillo, PhD^d ; David McDonnell, MD^e

Original Research

Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study

J Clin Psychiatry 2020;81(2):19m12731

Sanjeev Pathak, MD^a ; Ying Jiang, PhD^a ; Lauren DiPetrillo, PhD^a ; Mark S. Todtenkopf, PhD^a ; Yan Liu, PhD^a ; Christoph U. Correll, MD^b,c,d

Original Research

Early- Versus Adult-Onset Schizophrenia as a Predictor of Response to Neuroscience-Informed Cognitive Training

J Clin Psychiatry 2020;81(2):18m12369

Olga Puig, PhD^a ; Melissa Fisher, PhD^b ; Rachel Loewy, PhD^c ; Kathleen Miley, CNP^b ; Ian S. Ramsay, PhD^b ; Cameron S. Carter, MD^d ; John D. Ragland, PhD^d ; Tara Niendam, PhD^d ; Sophia Vinogradov, MD^b

Academic Highlights

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

J Clin Psychiatry 2020;81(2):TV18059AH3C

Leslie L. Citrome, MD, MPH ; Stephen R. Saklad, PharmD, BCPP

Commentary

A Growing Crisis in Schizophrenia Drug Development: Failing Signal Detection at North American and Other Clinical Trial Sites

J Clin Psychiatry 2020;81(2):19com13110

Thomas P. Laughren, MD, MD

Clinical and Practical Psychopharmacology

Antidepressant Prescription in Pregnancy: The Importance of Prenatal Maternal Anemia as a Potential Confound in Studies on Neurodevelopmental and Other Outcomes

J Clin Psychiatry 2020;81(2):20f13347

Chittaranjan Andrade, MD

Clinical and Practical Psychopharmacology

The Use and Limitations of the Fragility Index in the Interpretation of Clinical Trial Findings

J Clin Psychiatry 2020;81(2):20f13334

Chittaranjan Andrade, MD

ASCP Corner

Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review

J Clin Psychiatry 2020;81(2):19ac13071

Sara V. Carlini, MD^a ; Kristina M. Deligiannidis, MD^a,b,c

Letter to the Editor

Posttraumatic Stress Disorder and Binge-Eating Disorder: Further Context and Additional Findings From a Nationally Representative Sample of Adults in the United States

J Clin Psychiatry 2020;81(2):19lr13157

Carlos M. Grilo, PhD^a ; Tomoko Udo, PhD^b

Letter to the Editor

Dr Mota and Colleagues Reply

J Clin Psychiatry 2020;81(2):19lr13157a

Natalie Mota, PhD ; Joel Braun, MD, BSc ; Robert H. Pietrzak, PhD, MPH ; Renée El-Gabalawy, PhD ; Jordana L. Sommer, MA ; Karen Mitchell, PhD

Educational Activity

How Can Measurement-Based Care Help Improve Treatment Outcomes for Major Depressive Disorder in Primary Care?

J Clin Psychiatry 2020;81(2):UT17042BR2C

Madhukar H. Trivedi, MD

Educational Activity

Major Depressive Disorder in Primary Care: Strategies for Identification

J Clin Psychiatry 2020;81(2):UT17042BR1C

Madhukar H. Trivedi, MD

Educational Activity

Medication Options and Clinical Strategies for Treating Tardive Dyskinesia

J Clin Psychiatry 2020;81(2):TV18059BR2C

Leslie L. Citrome, MD, MPH

Educational Activity

Prevalence and Impact of Relapse in Patients With Schizophrenia

J Clin Psychiatry 2020;81(2):MS19053BR1C

John Lauriello, MD

Correction

Correction: Sublingual Ketamine

J Clin Psychiatry 2020;81(2):20lcx13316

Jennifer Swainson, MD ; Atul Khullar, MD, MSc

Correction

Correction: Oral Ketamine for Depression

J Clin Psychiatry 2020;81(2):20lcx13315

Joshua D. Rosenblat, MD ; Andre F. Carvalho, MD, PhD ; Madeline Li, MD, PhD ; Yena Lee, BSc ; Mehala Subramanieapillai, MSc ; Roger S. McIntyre, MD

Volume 81 • 2020 • 2

Editorial

COVID-19 From a Psychiatry Perspective: Meeting the Challenges

Consensus Statement

A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia

Meta-Analysis

The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses

Long-Term Outcomes of Postpartum Psychosis: A Systematic Review and Meta-Analysis

Review Article

New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature

The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration

Maintaining Rapid Antidepressant Effects Following Ketamine Infusion: A Major Unmet Need

Original Research

Types of Adult Attention-Deficit/Hyperactivity Disorder: A Replication Analysis

Suicidality, Depression, and the FDA: Health Inequities and the Ethical Conduct of Research

Relationship of Nocturnal Wakefulness to Suicide Risk Across Months and Methods of Suicide

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study

Disordered Aggression and Violence in the United States

Role of Hopelessness in Suicidal Ideation Among Patients With Depressive Disorders

Striatal Resting-State Connectivity Abnormalities Associated With Different Clinical Stages of Major Depressive Disorder

Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial

Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study

Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study

Early- Versus Adult-Onset Schizophrenia as a Predictor of Response to Neuroscience-Informed Cognitive Training

Academic Highlights

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Commentary

A Growing Crisis in Schizophrenia Drug Development: Failing Signal Detection at North American and Other Clinical Trial Sites

Clinical and Practical Psychopharmacology

Antidepressant Prescription in Pregnancy: The Importance of Prenatal Maternal Anemia as a Potential Confound in Studies on Neurodevelopmental and Other Outcomes

The Use and Limitations of the Fragility Index in the Interpretation of Clinical Trial Findings

ASCP Corner

Evidence-Based Treatment of Premenstrual Dysphoric Disorder: A Concise Review

Letter to the Editor

Posttraumatic Stress Disorder and Binge-Eating Disorder: Further Context and Additional Findings From a Nationally Representative Sample of Adults in the United States

Dr Mota and Colleagues Reply

Educational Activity

How Can Measurement-Based Care Help Improve Treatment Outcomes for Major Depressive Disorder in Primary Care?

Major Depressive Disorder in Primary Care: Strategies for Identification

Medication Options and Clinical Strategies for Treating Tardive Dyskinesia

Prevalence and Impact of Relapse in Patients With Schizophrenia

Correction

Correction: Sublingual Ketamine

Correction: Oral Ketamine for Depression

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles